Barone Francesca
SEC insider (Form 3/4/5 filer). CIK 0001909680. Chief Scientific Officer at Candel Therapeutics, Inc. (CADL). 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 29, 2026. Located in NEEDHAM, MA.
Companies Barone Francesca has filed insider reports for
- Candel Therapeutics, Inc. (CADL): Officer, Chief Scientific Officer
Barone Francesca
CIK: 0001909680
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Candel Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 29, 2026CADL
Candel Therapeutics, Inc.
SaleDirect23.4K shares at avg. $10.06$236K - Jan 26, 2026CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
232K shares- - Jun 25, 2025CADL
Candel Therapeutics, Inc.
AwardDirect4.3K shares at avg. $4.67$20K - Mar 18, 2025CADL
Candel Therapeutics, Inc.
SaleDirect32.1K shares at avg. $8.76$282K - Mar 18, 2025CADL
Candel Therapeutics, Inc.
ExerciseDirect18K shares at avg. $1.55$28K - Feb 12, 2025CADL
Candel Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
115K shares- - Jan 15, 2025CADL
Candel Therapeutics, Inc.
SaleDirect13.5K shares at avg. $7.22$98K - Jan 8, 2025CADL
Candel Therapeutics, Inc.
SaleDirect13.7K shares at avg. $8.22$112K - Nov 29, 2024CADL
Candel Therapeutics, Inc.
SaleDirect22.1K shares at avg. $4.56$101K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 29, 2026 | CADL Candel Therapeutics, Inc. | Sale | 23,447 | $10.06 | $235,769 | Direct |
| Jan 26, 2026 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 232,000 | - | - | Direct |
| Jun 25, 2025 | CADL Candel Therapeutics, Inc. | Award | 4,282 | $4.67 | $19,997 | Direct |
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | Sale | 32,146 | $8.76 | $281,673 | Direct |
| Mar 18, 2025 | CADL Candel Therapeutics, Inc. | Exercise | 18,000 | $1.55 | $27,900 | Direct |
| Feb 12, 2025 | CADL Candel Therapeutics, Inc. | Award Stock Option (Right to Buy) | 115,000 | - | - | Direct |
| Jan 15, 2025 | CADL Candel Therapeutics, Inc. | Sale | 13,534 | $7.22 | $97,783 | Direct |
| Jan 8, 2025 | CADL Candel Therapeutics, Inc. | Sale | 13,673 | $8.22 | $112,367 | Direct |
| Nov 29, 2024 | CADL Candel Therapeutics, Inc. | Sale | 22,081 | $4.56 | $100,592 | Direct |
1-9 of 9 transactions